Catalio Capital

Venture firm

Catalio Capital investment thesis

Home Strategies Overview Private Equity Structured Opportunities Public Equities Co-Investments Portfolio Team News Investor Login SEI Login MSFS Login Investor login SEI Login MSFS Login [Portfolio] Affini-T Visit website Affini-T is a preclinical-stage company developing T-cell therapeutics founded by Catalio Venture Partner and immunotherapy pioneer Dr. Phil Greenberg. Although cell therapies have transformed the care of some liquid tumors, they have shown little to no efficacy in solid tumors due to key issues in T-cell biology and a lack of viable tumor-specific targets. To address these limitations, Affini-T is advancing a novel series of precision T cell therapeutics for solid tumors, leveraging advances made in TCR engineering in the labs of its founders at the Fred Hutchinson Canc

Catalio Capital team (30)

Partners and principals at Catalio Capital:

Catalio Capital portfolio companies

Companies listed on Catalio Capital's public materials include: Strategies, Overview, Private Equity, Structured Opportunities, Public Equities, Co-Investments, Portfolio, Team, News, Investor Login, SEI Login, MSFS Login, Affini-T, Visit website, Back to portfolio, Security.

Is Catalio Capital a fit for your round?

Upload your pitch deck and see whether anyone at Catalio Capital appears in your top matches.

Find investors for your deck